This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from Monday 27th June. Learn more on the Digital Experience page.

Ron Brown
Owner and Prinicipal Toxicologist at Risk Science Consortium, LLC

Profile

Ron Brown is a toxicologist with 35 years of experience in regulatory toxicology and risk assessment.  He recently retired from the US FDA after 25 years of service and currently directs a small company, Risk Science Consortium, LLC, that provides consultation and training in toxicological risk assessment and provides support for companies developing New Approach Methods (NAMs) that can serve as alternatives to animals models for toxicity testing.  At the FDA, Ron was the senior toxicologist responsible for developing and reviewing toxicological risk assessments of extractable and leachable (E&L) compounds from medical devices.  Prior to his position at the US FDA, Ron served as a Senior Associate at the ILSI Risk Science Institute.  He is founding member and former President of the Medical Device and Combination Products Specialty Section of the Society of Toxicology and former President of the Dose-Response Specialty Section of the Society for Risk Analysis.

Agenda Sessions

  • Regulations for Chemical Characterization & Toxicological Risk Assessments

    15:50
  • Panel: The Challenges in Toxicological Risk Assessments

    16:20
  • “Ask the Experts” Panel Discussion: Biocompatibility

    15:00